Corifollitropin alfa N01 Injection

绒促卵泡激素α N01

Report date: 2025/09/02 15:01:35

Base Information

Drug NameCorifollitropin alfa N01 Injection
Drug Alias NameRecombinant human follicle-stimulating hormone-CTP fusion protein重组人卵泡刺激素-CTP融合蛋白绒促卵泡激素α N01注射液Corifollitropin alfa N01绒促卵泡激素αN01 +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionFollicle-stimulating hormone replacements
TargetsFollicle-stimulating hormone
Therapy Area/IndicationsInfertility, Female
Global Approved IndicationsInfertility, Female
Approved Indications in ChinaInfertility, Female
Original Approved Country/TerritoryMainland China
Original Approved Date2025/08/19
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSuzhou Shengji Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Shengji Pharmaceutical Co Ltd
Inactive CompaniesSuzhou Kangju Biotechnology Co Ltd
Active IndicationsInfertility, Female
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A